Site-specific Gene Modification by PNAs Conjugated to Psoralen
Overview
Authors
Affiliations
DNA-binding molecules, including triplex-forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs), can be utilized to introduce site-specific mutations or to promote recombination at selected genomic sites. To further evaluate the utility of PNAs for site-specific gene modification, we tested dimeric bis-PNAs conjugated to psoralen. These PNAs are designed to form a triplex-invasion complex within the supF reporter gene in an episomal shuttle vector and to direct site-specific photoadduct formation by the conjugated psoralen. The psoralen-bis-PNA conjugate was found to direct photoadduct formation to the intended 5'-TpA base step next to the PNA-binding site, and the photoadduct formation efficiency displayed both concentration and UVA irradiation dependence. The effect of PNA-targeted photoadducts in a mammalian system was tested by SV40-based shuttle vector assay. After in vitro binding, we found that photoadducts directed by PNAs conjugated to psoralen-induced mutations at frequencies in the range of 0.46%, 6.5-fold above the background. In a protocol for intracellular gene targeting in the episomal shuttle vector, the psoralen-PNA-induced mutation frequency was 0.13%, 3.5-fold higher than the background. Most of the induced mutations were deletions and single-base-pair substitutions at or adjacent to the targeted PNA-binding and photoadduct-formation sites. When the results are taken together, they demonstrate the ability of bis-PNAs conjugated with psoralen to mediate site-specific gene modification, and they further support the development of PNAs as tools for gene-targeting applications.
Oyaghire S, Quijano E, Perera J, Mandl H, Saltzman W, Bahal R Cell Rep Phys Sci. 2023; 4(10).
PMID: 37920723 PMC: 10621889. DOI: 10.1016/j.xcrp.2023.101635.
Hutchinson M, Deeyaa B, Byrne S, Williams S, Rokita S Bioconjug Chem. 2020; 31(5):1486-1496.
PMID: 32298588 PMC: 7242154. DOI: 10.1021/acs.bioconjchem.0c00166.
Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.
Oyaghire S, Quijano E, Piotrowski-Daspit A, Saltzman W, Glazer P Methods Mol Biol. 2020; 2105:261-281.
PMID: 32088877 PMC: 7199467. DOI: 10.1007/978-1-0716-0243-0_17.
Genome Editing: Past, Present, and Future.
Carroll D Yale J Biol Med. 2017; 90(4):653-659.
PMID: 29259529 PMC: 5733845.
Nanotechnology for delivery of peptide nucleic acids (PNAs).
Gupta A, Bahal R, Gupta M, Glazer P, Saltzman W J Control Release. 2016; 240:302-311.
PMID: 26776051 PMC: 5016210. DOI: 10.1016/j.jconrel.2016.01.005.